These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35448463)

  • 1. MetaboListem and TABoLiSTM: Two Deep Learning Algorithms for Metabolite Named Entity Recognition.
    Yeung CS; Beck T; Posma JM
    Metabolites; 2022 Mar; 12(4):. PubMed ID: 35448463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vocabulary Matters: An Annotation Pipeline and Four Deep Learning Algorithms for Enzyme Named Entity Recognition.
    Wang M; Vijayaraghavan A; Beck T; Posma JM
    J Proteome Res; 2024 Jun; 23(6):1915-1925. PubMed ID: 38733346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adversarial active learning for the identification of medical concepts and annotation inconsistency.
    Yu G; Yang Y; Wang X; Zhen H; He G; Li Z; Zhao Y; Shu Q; Shu L
    J Biomed Inform; 2020 Aug; 108():103481. PubMed ID: 32687985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedical named entity recognition using deep neural networks with contextual information.
    Cho H; Lee H
    BMC Bioinformatics; 2019 Dec; 20(1):735. PubMed ID: 31881938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An imConvNet-based deep learning model for Chinese medical named entity recognition.
    Zheng Y; Han Z; Cai Y; Duan X; Sun J; Yang W; Huang H
    BMC Med Inform Decis Mak; 2022 Nov; 22(1):303. PubMed ID: 36411432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BioBERT: a pre-trained biomedical language representation model for biomedical text mining.
    Lee J; Yoon W; Kim S; Kim D; Kim S; So CH; Kang J
    Bioinformatics; 2020 Feb; 36(4):1234-1240. PubMed ID: 31501885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracting comprehensive clinical information for breast cancer using deep learning methods.
    Zhang X; Zhang Y; Zhang Q; Ren Y; Qiu T; Ma J; Sun Q
    Int J Med Inform; 2019 Dec; 132():103985. PubMed ID: 31627032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Text Mining Pipeline Using Active and Deep Learning Aimed at Curating Information in Computational Neuroscience.
    Shardlow M; Ju M; Li M; O'Reilly C; Iavarone E; McNaught J; Ananiadou S
    Neuroinformatics; 2019 Jul; 17(3):391-406. PubMed ID: 30443819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracting clinical named entity for pituitary adenomas from Chinese electronic medical records.
    Fang A; Hu J; Zhao W; Feng M; Fu J; Feng S; Lou P; Ren H; Chen X
    BMC Med Inform Decis Mak; 2022 Mar; 22(1):72. PubMed ID: 35321705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extract antibody and antigen names from biomedical literature.
    Dinh TT; Vo-Chanh TP; Nguyen C; Huynh VQ; Vo N; Nguyen HD
    BMC Bioinformatics; 2022 Dec; 23(1):524. PubMed ID: 36474140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DeIDNER Model: A Neural Network Named Entity Recognition Model for Use in the De-identification of Clinical Notes.
    Syed M; Sexton K; Greer M; Syed S; VanScoy J; Kawsar F; Olson E; Patel K; Erwin J; Bhattacharyya S; Zozus M; Prior F
    Biomed Eng Syst Technol Int Jt Conf BIOSTEC Revis Sel Pap; 2022 Feb; 5():640-647. PubMed ID: 35386186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug knowledge discovery via multi-task learning and pre-trained models.
    Li D; Xiong Y; Hu B; Tang B; Peng W; Chen Q
    BMC Med Inform Decis Mak; 2021 Nov; 21(Suppl 9):251. PubMed ID: 34789238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning-based methods for natural hazard named entity recognition.
    Sun J; Liu Y; Cui J; He H
    Sci Rep; 2022 Mar; 12(1):4598. PubMed ID: 35301387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing general and specialized word embeddings for biomedical named entity recognition.
    Ramos-Vargas RE; Román-Godínez I; Torres-Ramos S
    PeerJ Comput Sci; 2021; 7():e384. PubMed ID: 33817030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Document-level attention-based BiLSTM-CRF incorporating disease dictionary for disease named entity recognition.
    Xu K; Yang Z; Kang P; Wang Q; Liu W
    Comput Biol Med; 2019 May; 108():122-132. PubMed ID: 31003175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracting Drug Names and Associated Attributes From Discharge Summaries: Text Mining Study.
    Alfattni G; Belousov M; Peek N; Nenadic G
    JMIR Med Inform; 2021 May; 9(5):e24678. PubMed ID: 33949962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of disease named entity recognition on a corpus of annotated sentences.
    Jimeno A; Jimenez-Ruiz E; Lee V; Gaudan S; Berlanga R; Rebholz-Schuhmann D
    BMC Bioinformatics; 2008 Apr; 9 Suppl 3(Suppl 3):S3. PubMed ID: 18426548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study on deep learning models for text classification of unstructured medical notes with various levels of class imbalance.
    Lu H; Ehwerhemuepha L; Rakovski C
    BMC Med Res Methodol; 2022 Jul; 22(1):181. PubMed ID: 35780100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of clinical named entity recognition methods for Serbian electronic health records.
    Kaplar A; Stošović M; Kaplar A; Brković V; Naumović R; Kovačević A
    Int J Med Inform; 2022 Aug; 164():104805. PubMed ID: 35653828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Named entity recognition from Chinese adverse drug event reports with lexical feature based BiLSTM-CRF and tri-training.
    Chen Y; Zhou C; Li T; Wu H; Zhao X; Ye K; Liao J
    J Biomed Inform; 2019 Aug; 96():103252. PubMed ID: 31323311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.